SMMT
Summit Therapeutics Inc Earnings
$25.91
Earnings Summary
Revenue | $0Mn |
Net Profits | $-62.91Mn |
Net Profit Margins | -Inf% |
Summit Therapeutics Inc’s revenue jumped NaN% since last year same period to $0Mn in the Q1 2025. On a quarterly growth basis, Summit Therapeutics Inc has generated NaN% jump in its revenue since last 3-months.
Summit Therapeutics Inc’s net profit fell -44.72% since last year same period to $-62.91Mn in the Q1 2025. On a quarterly growth basis, Summit Therapeutics Inc has generated -2.79% fall in its net profits since last 3-months.
Summit Therapeutics Inc’s net profit margin jumped NaN% since last year same period to -Inf% in the Q1 2025. On a quarterly growth basis, Summit Therapeutics Inc has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | -0.1 |
EPS Estimate Current Year | -0.1 |
Summit Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.1 - a -10.85% fall from last quarter’s estimates.
Summit Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.1.
Key Ratios
Earning Per Share (EPS) | 0 |
Summit Therapeutics Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q2 2025. This indicates that the Summit Therapeutics Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-05-01 | -0.07 | -0.07 | 0.73% |
2025-08-06 | -0.09 | 0 | 100% |
